Aptamers Market is estimated to be worth over USD 2.9 billion in 2024, and is poised for substantial expansion through 2032, driven by rising adoption in precision diagnostics, targeted therapeutics, and biomarker discovery. Key factors such as increasing investment in personalized medicine and rapid technological advancement in aptamer selection are fueling this momentum. To...